Differential effects of morphine-6-glucuronide, an active metabolite of morphine, and morphine on locomotor activity in mice: Involvement of the opioid receptor

Pharmacology and Toxicology

Volumn 78, Issue 5, 1996, Pages 322-326

  Uchihashi, Yoshitaka ^a   Kuribara, Hisashi ^b   Morita, Toshihiro ^c   Kitani, Yasuharu ^c   Karasawa, Fujio ^a   Sato, Tetsuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Behaviour Research Institute   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DRUG METABOLITE; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029941816     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb01383.x     Document Type: Article

References (17)

1. Abbott, F. V. & R. M. Palmour: Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 1988, 43, 1685-1695.
2. Chen, Z. R., R. J. Irvine, A. A. Somogyi & F. Bochner: Mu receptor binding of some commonly used opioids and their metabolites. Life Sci. 1991, 48, 2165-2171.
3. Christensen, C. B. & L. N. Jorgensen: Morphine-6-glucuronide: has high affinity for the opioid receptor. Pharmacology & Toxicology 1987, 60, 75-76.
4. Christensen, C. B. & L. Reiff: Morphine-6-glucuronide receptor binding profile in bovine caudate nucleus. Pharmacology & Toxicology 1991, 68, 151-153.
5. Corbett, A. D., S. J. Paterson & H. W. Kosterlitz: Selectivity of ligands for opioid receptors. In: Handbook of experimental pharmacology, vol. 104, Opioids I. Ed.: A. Herz. Springer-Verlag, Berlin, 1993, pp. 645-679.
6. Cowan, A.: Effects of opioids on the spontaneous behavior of animals. In: Handbook of experimental pharmacology, vol. 104, Opioids II. Ed.: A. Herz. Springer-Verlag, Berlin, 1993, pp. 393-428.
7. Frances, B., R. Gout, B. Monsarrat, J. Cros & J.-M. Zajac: Further evidence that morphine-6β-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Therap. 1992, 262, 25-31.
8. Gong, Q. L., T. Hender, R. Björkman & G. Nordberg: Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur. J. Pharmacol. 1991, 193, 47-56.
9. Hirabayashi, M., M. Iizuka & S. Tadokoro: Simple and easy method for measurement of ambulatory activity in mice. Nippon Yakurigaku Zasshi 1978, 74, 629-639.
10. Hucks, D., P. I. Thompson, L. McLoughlin, S. P. Joel, N. Patel, A. Grossman, L. H Rees & M. L. Slevin: Explanation at the opioid receptor level for differing toxicity of morphine and morphine-6-glucoronide. Brit. J. Cancer 1992, 65, 122-126.
11. Kuribara, H., T. Asahi & S. Tadokoro: The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine. Jap. J. Alcohol Drug Dep. 1991, 26, 37-48.
12. Mørland, J., B. L. Jones, M. L. Palomares & R. L. Alkana: Morphine-6-glucuronide: a potent stimulator of locomotor activity in mice. Life Sci 1994, 55, 163-168.
13. Oguri, K., I. Yamada-Mori, J. Shigezune, T. Hirano & H. Yoshimura: Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position. Life Sci. 1987, 41, 1457-1464.
14. Pasternak, G. W.: Opioid receptors: In: Psychopharmacology. Ed.: H. Y. Meltzer. Raven Press, New York, 1987, pp. 281-288.
15. Pasternak, G. W., R. J. Bodnar, J. A. Clark & C. E. Inturrisi: Morphin-6-glucuronide, a potent mu agonist. Life Sci. 1987, 41, 2845-2849.
16. Paul, D., K. M. Standifer, C. E. Inturrisi & G. W. Pasternak: Pharmacological characterization of morphine-6-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Therap. 1989, 251, 477-483.
17. Portoghese, P. S., M. Sultana & A. E. Takemori: Naltrindole, a highly selective and potent non-peptide δ-opioid receptor antagonist. Eur. J Pharmacol. 1988, 146, 185-186.